BBIO

BridgeBio Pharma, Inc. Common Stock

64.94

USD

+1.64

+2.59%

Oct 14, 15:59 UTC -4

Closed

After-Market

65.90

+0.96

+1.47%

BBIO Earnings Reports

Positive Surprise Ratio

BBIO beat 8 of 29 last estimates.

28%

Next Report

Date of Next Report

Oct 29, 2026

Estimate for Q3 26 (Revenue/ EPS)

$275.64M

-$0.65

Implied change from Q2 26 (Revenue/ EPS)

+13.12%

-16.67%

Implied change from Q3 25 (Revenue/ EPS)

+128.37%

-31.58%

BridgeBio Pharma, Inc. Common Stock earnings per share and revenue

On Aug 10, 2026, BBIO reported earnings of -0.78 USD per share (EPS) for Q2 26, missing the estimate of -0.59 USD, resulting in a -31.07% surprise. Revenue reached 243.68 million, compared to an expected 223.12 million, with a 9.21% difference. The market reacted with a -1.15% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 13 analysts forecast an EPS of -0.65 USD, with revenue projected to reach 275.64 million USD, implying an decrease of -16.67% EPS, and increase of 13.12% in Revenue from the last quarter.

FAQ

What were BridgeBio Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, BridgeBio Pharma, Inc. Common Stock reported EPS of -$0.78, missing estimates by -31.07%, and revenue of $243.68M, 9.21% above expectations.

How did the market react to BridgeBio Pharma, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -1.15%, changed from $84.67 before the earnings release to $83.70 the day after.

When is BridgeBio Pharma, Inc. Common Stock expected to report next?

The next earning report is scheduled for Oct 29, 2026.

What are the forecasts for BridgeBio Pharma, Inc. Common Stock's next earnings report?

Based on 13 analysts, BridgeBio Pharma, Inc. Common Stock is expected to report EPS of -$0.65 and revenue of $275.64M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.